| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/06/2000 | WO2000039291A1 Virus-resistant transgenic plants expressing l3 |
| 07/06/2000 | WO2000039289A2 Endo-beta-1,4-xylanase inhibitor aus weizenmehl und seine wirkung auf verschiedene xylanasen |
| 07/06/2000 | WO2000039286A1 DnaE |
| 07/06/2000 | WO2000039284A1 Secreted proteins and nucleic acids encoding them |
| 07/06/2000 | WO2000039280A2 Leukocyte-derived interferon preparations |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039278A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 07/06/2000 | WO2000039277A2 Ndsp nucleic acids and polypeptides |
| 07/06/2000 | WO2000039166A1 Novel hyaluronan-binding proteins and encoding genes |
| 07/06/2000 | WO2000039165A1 Serine protease inhibitor |
| 07/06/2000 | WO2000039164A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor protein |
| 07/06/2000 | WO2000039163A1 Modification of interferon alpha production |
| 07/06/2000 | WO2000039162A1 Human wnt-7a polypeptide and polynucleotide |
| 07/06/2000 | WO2000039161A1 Class ii cytokine receptor-like proteins and nucleic acids encoding them |
| 07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
| 07/06/2000 | WO2000039159A1 Superantigens |
| 07/06/2000 | WO2000039158A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039155A1 PENICILLINS AS PHARMACEUTICALS FOR THE DOWNREGULATION OF IFNη PRODUCTION |
| 07/06/2000 | WO2000039154A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 07/06/2000 | WO2000039153A1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
| 07/06/2000 | WO2000039152A1 Stable subtilin and methods of manufacture |
| 07/06/2000 | WO2000039151A1 Neutralizing assay using human papillomavirus virus-like particles |
| 07/06/2000 | WO2000039150A2 Secreted proteins and uses thereof |
| 07/06/2000 | WO2000039149A2 Secreted proteins and uses thereof |
| 07/06/2000 | WO2000039147A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 07/06/2000 | WO2000039136A2 Human brainiac-5 |
| 07/06/2000 | WO2000038733A1 Peptidic product, process and composition |
| 07/06/2000 | WO2000038713A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | WO2000038707A1 Method for the treatment of bone loss |
| 07/06/2000 | WO2000038706A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 07/06/2000 | WO2000038704A1 Use of peptide |
| 07/06/2000 | WO2000038654A1 Synthetic and therapeutic methods for the alpha and beta domains of metallothionein |
| 07/06/2000 | WO2000038515A1 Peptide mimics useful for treating disease |
| 07/06/2000 | WO2000024899A3 Interleukin-1 homolog zil1a4 |
| 07/06/2000 | WO2000022125A3 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 07/06/2000 | WO2000022124A3 Methods and compositions to induce antitumor response |
| 07/06/2000 | WO2000021988A3 Human ankyrin family protein |
| 07/06/2000 | WO2000020612A3 Therapeutically active proteins in plants |
| 07/06/2000 | WO2000020607A3 Chimaeric proteins between members of tgf-beta superfamily |
| 07/06/2000 | WO2000020591A3 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 07/06/2000 | WO2000020588A3 Bone marrow-derived serum proteins |
| 07/06/2000 | WO2000020584A3 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 07/06/2000 | WO2000020452A3 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 07/06/2000 | WO2000018954A3 Use of pex in the treatment of metabolic bone diseases |
| 07/06/2000 | WO2000017355A3 Human cytoskeleton associated proteins |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000016061B1 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates |
| 07/06/2000 | WO2000014222A3 Gabab receptor subtypes gabab-r1c and gabab-r2 and heterodimers thereof |
| 07/06/2000 | WO2000011147A9 Inbred mhc-homozygous miniature swine and uses thereof |
| 07/06/2000 | WO2000011028A3 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 07/06/2000 | WO2000009698A3 Compounds useful to affect resistance in plants and methods related thereto |
| 07/06/2000 | WO2000009689A3 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 07/06/2000 | WO2000005414A9 Linking gene sequence to gene function by three dimensional (3d) protein structure determination |
| 07/06/2000 | WO2000003017A3 Enhancer elements for increased translation in plant plastids |
| 07/06/2000 | WO2000000616A3 Marburg virus vaccines |
| 07/06/2000 | WO1999066030A9 Dap-kinase related protein |
| 07/06/2000 | WO1999063087A9 G-protein coupled receptor, named 2871 receptor |
| 07/06/2000 | WO1999061600A9 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/06/2000 | WO1999054461A3 Human nucleic acid sequences of endometrium tumour tissue |
| 07/06/2000 | WO1999054448A3 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue |
| 07/06/2000 | WO1999054447A3 Human nucleic acid sequences of bladder tumour tissue |
| 07/06/2000 | WO1999053040A3 Human nucleic acid sequences from ovarian tumour tissue |
| 07/06/2000 | WO1999051727A3 Human nucleic acid sequences of normal ovary tissue |
| 07/06/2000 | WO1999047655A3 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 07/06/2000 | WO1999047535A9 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 07/06/2000 | WO1999046375A3 Human nucleic acid sequences from prostate tissue |
| 07/06/2000 | WO1999046374A3 Human nucleic acid sequences from prostate tumour tissue |
| 07/06/2000 | WO1999041282A8 Therapeutic uses of keratinocyte growth factor-2 |
| 07/06/2000 | DE19860801A1 Rekombinanter Wachstumsfaktor mit der biologischen Aktivität eines G-CSF (Granulocyte Colony Stimulating Factor) Recombinant growth factor having the biological activity of a G-CSF (Granulocyte Colony Stimulating Factor) |
| 07/06/2000 | DE19859486A1 New peptide with high antiproliferative activity, useful for treating cancer or psoriasis, comprises a nuclear localization sequence and a fragment of the retinoblastoma protein |
| 07/06/2000 | DE19858188A1 Apparatus for dissolving albumin flakes in a liquid contained in a bottle of circular cross-section. |
| 07/06/2000 | CA2719413A1 Compositions and methods for packaging of alphavirus vectors |
| 07/06/2000 | CA2363999A1 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358385A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | CA2357036A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 07/06/2000 | CA2357031A1 Novel hyaluronan-binding proteins and encoding genes |
| 07/06/2000 | CA2356955A1 Stable subtilin and methods of manufacture |
| 07/06/2000 | CA2356777A1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
| 07/06/2000 | CA2356755A1 Superantigens |
| 07/06/2000 | CA2356661A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |
| 07/06/2000 | CA2356542A1 Peptidoglycan recognition proteins |
| 07/06/2000 | CA2356424A1 Serine protease inhibitor |
| 07/06/2000 | CA2356243A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor proteins |
| 07/06/2000 | CA2356186A1 Penicillins as pharmaceuticals for the downregulation of ifn.gamma. production |
| 07/06/2000 | CA2356057A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2355883A1 Neutralizing assay using human papillomavirus virus-like particles |
| 07/06/2000 | CA2355632A1 Ucp-2 promoter dna |
| 07/06/2000 | CA2355254A1 Use of peptide |
| 07/06/2000 | CA2354542A1 Transgenic rodents and rodent cell lines expressing hiv co-receptors |
| 07/06/2000 | CA2354431A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2354027A1 Il-1 related polypeptides |
| 07/06/2000 | CA2334958A1 Peptide mimics useful for treating disease |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/06/2000 | CA2292798A1 Novel vector for introducing a gene into a plant using a selectable marker |
| 07/05/2000 | EP1016724A2 Plasmids expressing the trigger factors GroEL or GroES |
| 07/05/2000 | EP1016723A1 Recombinant synthesis of beta-Lipotropin and other peptides |